We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMAO icon
3101
Farmers & Merchants Bancorp
FMAO
$489M
$27K ﹤0.01%
1,113
+380
+52% +$9.97K
GBX icon
3102
The Greenbrier Companies
GBX
$1.41B
$27K ﹤0.01%
856
-1,235
-59% -$37.3K
GIC icon
3103
Global Industrial
GIC
$1.48B
$27K ﹤0.01%
1,015
+559
+123% +$14.8K
GOGL
3104
DELISTED
Golden Ocean Group
GOGL
$27K ﹤0.01%
2,852
+2
+0.1% +$19
GSAT icon
3105
Globalstar
GSAT
$10.6B
$27K ﹤0.01%
1,568
-4,687
-75% -$86.4K
HCSG icon
3106
Healthcare Services Group
HCSG
$1.48B
$27K ﹤0.01%
1,998
-220
-10% -$2.9K
HQI icon
3107
HireQuest
HQI
$240M
$27K ﹤0.01%
1,230
-109
-8% -$2.31K
HUYA
3108
Huya Inc
HUYA
$531M
$27K ﹤0.01%
7,613
-24
-0.3% -$113
IMRX icon
3109
Immuneering
IMRX
$331M
$27K ﹤0.01%
2,768
-3,608
-57% -$20.5K
KRO icon
3110
KRONOS Worldwide
KRO
$979M
$27K ﹤0.01%
2,896
-34
-1% -$357
LTRX icon
3111
Lantronix
LTRX
$292M
$27K ﹤0.01%
6,098
-4,318
-41% -$20.2K
MED icon
3112
Medifast
MED
$130M
$27K ﹤0.01%
260
-221
-46% -$24.5K
MTEX icon
3113
Mannatech
MTEX
$10.4M
$27K ﹤0.01%
1,575
+987
+168% +$16.8K
NECB icon
3114
Northeast Community Bancorp
NECB
$373M
$27K ﹤0.01%
2,039
+611
+43% +$9.15K
NMRK icon
3115
Newmark Group
NMRK
$2.74B
$27K ﹤0.01%
3,793
-12,651
-77% -$101K
NUTX
3116
Nutex Health
NUTX
$1.33B
$27K ﹤0.01%
178
+152
+585% +$30.8K
TEAD
3117
Teads Holding Co
TEAD
$66.4M
$27K ﹤0.01%
6,564
+3,664
+126% +$16.6K
OBK icon
3118
Origin Bancorp
OBK
$1.68B
$27K ﹤0.01%
853
-344
-29% -$12.6K
OPEN icon
3119
Opendoor
OPEN
$3.51B
$27K ﹤0.01%
15,822
-28,658
-64% -$47.2K
PAYS icon
3120
Paysign
PAYS
$737M
$27K ﹤0.01%
7,476
+1,445
+24% +$4.94K
PBI icon
3121
Pitney Bowes
PBI
$2.25B
$27K ﹤0.01%
6,970
+5,392
+342% +$22.7K
QUIK icon
3122
QuickLogic
QUIK
$234M
$27K ﹤0.01%
4,558
+569
+14% +$3.25K
RDNT icon
3123
RadNet
RDNT
$6.06B
$27K ﹤0.01%
1,078
+493
+84% +$10.7K
REPX icon
3124
Riley Exploration Permian
REPX
$795M
$27K ﹤0.01%
710
+371
+109% +$12K
SRI icon
3125
Stoneridge
SRI
$203M
$27K ﹤0.01%
1,453
-3,477
-71% -$74.7K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.